In SAM et al. v. Kennedy (1:26-cv-01081), the Court Weighs Whether CMS Overstepped Its Authority by allowing Hemp, Marijuana Cannabinoid Access Without FDA Approval. Duane Boise, CEO of MMJ ...
Millions of people with Medicare will soon be eligible to get discounted GLP-1 drugs for weight loss. Here's how it will work ...
Starting in July, certain Medicare enrollees can pay $50 a month for specific prescription GLP1 medications, according to the ...
The Centers for Medicare & Medicaid Services will provide eligible Medicare beneficiaries monthly access to certain GLP-1 medications for $50 per month beginning July 1, 2026, through December 31, ...
The BALANCE program was intended to cover weight-loss drugs for Medicaid beneficiaries, but is delayed. A new solution with ...
Verywell Health on MSN
Medicare program to offer GLP-1 drugs for $50 per month starting in July
Fact checked by Jennifer Klump Key Takeaways The Medicare GLP-1 Bridge program will cover weight loss drugs for a $50 monthly ...
Starting July 2026, Medicare will pilot the 'GLP-1 Bridge,' a temporary program allowing some retirees coverage for weight loss drugs like Wegovy and Zepbound. The initiative marks a shift from ...
The Centers for Medicare & Medicaid Services (CMS) has announced that its temporary program to cover GLP-1 drugs for obesity in Medicare.
Medicare delayed a plan to make insurance companies cover GLP-1 drugs Wegovy and Zepbound. Instead, Medicare will cover the ...
The Trump administration decided to put the pilot on hold until at least 2027.
Centers for Medicare and Medicaid Services COO Kim Brandt talked about her agency’s use cases for artificial intelligence in the ongoing battle against fraudulent medical claims. The Centers for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results